Tomer Wasserman

Tomer Wasserman has extensive experience in the oncology field, having held key leadership roles at several prominent companies. At Menarini Stemline from January 2022 to May 2023, Tomer served as Vice President and Head of Global Medical Affairs for Solid Tumors, and also as Global Oncology Lead for Solid Tumors. Prior to that, Tomer was with AstraZeneca from December 2018 to December 2021 as Global Immuno-Oncology Director for Lung Cancer and South LatAm Oncology Business Unit Director. Tomer's career began at Roche, where roles included Oncology Marketing Unit Manager for Immuno-Oncology and Market Access Operations Manager in Oncology. Earlier experience includes positions at Sanatorio de la Providencia, such as Clinical Research Site Manager and ICU Medical Coordinator. Tomer is further advancing expertise in clinical drug development through a certificate program at Harvard Medical School and has completed an Executive Strategy Programme at Saïd Business School, University of Oxford.